Drug intelligence / Profile preview

Jiangru No. 2 formula

Development stage: Unknown
Lead developer: China-Japan Friendship Hospital
Administration: Oral

Overview

Jiangru No. 2 formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by the China-Japan Friendship Hospital for the treatment of non-puerperal mastitis (NPM), including conditions such as granulomatous lobular mastitis and plasma cell mastitis. The formula is specifically utilized during the abscess stage of the disease to clear heat, resolve toxins, and dissipate inflammatory nodules. In clinical practice, it is often administered orally as part of a comprehensive TCM regimen that includes fire needle therapy, and it is studied as an alternative to modern medical interventions like systemic corticosteroids and broad-spectrum antibiotics.

Other names: Jiangru No. 2Jiangru 2 Hao FangJiangru2 Hao FangJiangru-2 Hao Fang降乳2号方

Beyond the preview

Go deeper on Jiangru No. 2 formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangru No. 2 formula.

Explore the full profile